Nicholas Galifianakis, MD

Title(s)Professor, Neurology
SchoolSchool of Medicine
PronounsHe/Him/His
vCardDownload vCard
    Other Positions
    Title(s)UCSF Weill Institute for Neurosciences


    Collapse Biography 
    Collapse education and training
    Johns Hopkins UniversityB.A.1997
    Boston UniversityM.P.H.1999Public Health/Epidemiology
    University of Southern CaliforniaM.D.2003School of Medicine
    University of Southern CaliforniaResidency2007Neurology
    University of PennsylvaniaFellowship2008Parkinson's/Movement Disorders
    University of California San FranciscoFellowship2009Parkinson's/Movement Disorders
    University of California San Francisco2020Diversity, Equity, and Inclusion Champion Training

    Collapse Overview 
    Collapse overview
    Dr. Nicholas Galifianakis is a neurologist who specializes in taking a comprehensive approach to treating Parkinson's disease, essential tremor, dystonia and other movement disorders. His tools include deep brain stimulation, botulinum toxin injections and medication.

    Galifianakis' research interests include outcomes in deep brain stimulation for patients with Parkinson's disease and essential tremor, such as with the use of new interventional MRI techniques. He also is interested in defining types of essential tremor and developing more complete models of care for advanced Parkinson's disease.

    Galifianakis earned his medical degree and completed a neurology residency at the University of Southern California, where he served as chief resident. He completed a movement disorders fellowship at the University of Pennsylvania and UCSF.

    Galifianakis also sees patients at the Parkinson's Disease Research, Education and Clinical Center in San Francisco, a Veterans Affairs center of excellence. He is a member of the American Academy of Neurology and International Parkinson and Movement Disorder Society.

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Integrating tele-palliative care for atypical Parkinsonian disorders: Lessons learned from a pilot program. Clinical Parkinsonism & Related Disorders. 2025 Jan 1; 12:100352. Afshari AM, Kang KK, Butala BA, Guenther GJ, Razzak RR, Katz KM, Galifianakis GN, Pantelyat PA. .
      View in: Publisher Site   Mentions:
    2. Modeling and Optimizing Deep Brain Stimulation to Enhance Gait in Parkinson's Disease: Personalized Treatment with Neurophysiological Insights. medRxiv. 2024 Nov 01. Azgomi HF, Louie KH, Bath JE, Presbrey KN, Balakid JP, Marks JH, Wozny TA, Galifianakis NB, Luciano MS, Little S, Starr PA, Wang DD. PMID: 39574845; PMCID: PMC11581078.
      View in: PubMed   Mentions:
    3. Elevated Mood Induced by Subthalamic Nucleus Deep Brain Stimulation: A Video-Recorded Case Report. Tremor Other Hyperkinet Mov (N Y). 2024; 14:37. Coutinho PB, Johnson KA, Seritan AL, Galifianakis NB, Coleman R, Wang D, Racine CA, Ostrem JL, Starr PA, de Hemptinne C. PMID: 39005242; PMCID: PMC11243764.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Patient and Family Outcomes of Community Neurologist Palliative Education and Telehealth Support in Parkinson Disease. JAMA Neurol. 2024 Jan 01; 81(1):39-49. Kluger BM, Katz M, Galifianakis NB, Pantilat SZ, Hauser JM, Khan R, Friedman C, Vaughan CL, Goto Y, Long SJ, Martin CS, Dini M, McQueen RB, Palmer L, Fairclough D, Seeberger LC, Sillau SH, Kutner JS. PMID: 37955923; PMCID: PMC10644250.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    5. The "Surprise Question" for Prognostication in People With Parkinson's Disease and Related Disorders. J Pain Symptom Manage. 2024 01; 67(1):e1-e7. Mahes A, Macchi ZA, Martin CS, Katz M, Galifianakis NB, Pantilat SZ, Kutner JS, Sillau S, Kluger BM. PMID: 37838080; PMCID: PMC11068019.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    6. Development and Dissemination of a Neurology Palliative Care Curriculum: Education in Palliative and End-of-Life Care Neurology. Neurol Clin Pract. 2022 Apr; 12(2):176-182. Kluger BM, Kramer NM, Katz M, Galifianakis NB, Pantilat S, Long J, Vaughan CL, Foster LA, Creutzfeldt CJ, Holloway RG, Sillau S, Hauser J. PMID: 35747891; PMCID: PMC9208408.
      View in: PubMed   Mentions: 8  
    7. Prevalence and Cumulative Incidence of Caregiver-Reported Aggression in Advanced Parkinson Disease and Related Disorders. Neurol Clin Pract. 2021 Dec; 11(6):e826-e833. Macchi ZA, Miyasaki J, Katz M, Galifianakis N, Sillau S, Kluger BM. PMID: 34992965; PMCID: PMC8723973.
      View in: PubMed   Mentions: 4  
    8. 10 Year Clinical Outcomes of Subthalamic Nucleus versus Pallidal Deep Brain Stimulation for Parkinson’s Disease: VA/NINDS CSP #468F (4312). Neurology. 2021 Apr 13; 96(15_supplement). Ostrem OJ, Luo LP, Weaver WF, Follett FK, Galifianakis GN, Lai LE, Bronstein BJ, Duda DJ, Holloway HK, Sarwar SA, Brodsky BM, Chung CK, Spindler SM, Reda RD, Rothland RJ, Snodgrass SA, Marks MW. .
      View in: Publisher Site   Mentions:
    9. The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonism. NPJ Parkinsons Dis. 2021 Mar 01; 7(1):16. Tanner CM, Cummings SR, Schwarzschild MA, Brown EG, Dorsey ER, Espay AJ, Galifianakis NB, Goldman SM, Litvan I, Luthra N, McFarland NR, Mitchell KT, Standaert DG, Bauer DC, Greenspan SL, Beck JC, Lyles KW. PMID: 33649343; PMCID: PMC7921548.
      View in: PubMed   Mentions: 6  
    10. The presence of a caregiver is associated with patient outcomes in patients with Parkinson's disease and atypical parkinsonisms. Parkinsonism Relat Disord. 2020 09; 78:61-65. Prizer LP, Kluger BM, Sillau S, Katz M, Galifianakis NB, Miyasaki JM. PMID: 32736164.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    11. Medical education in movement disorders during the COVID-19 pandemic. Parkinsonism Relat Disord. 2020 08; 77:11-12. Zuzuárregui JRP, Bledsoe IO, Brown EG, Dietiker CG, Galifianakis NB. PMID: 32570192; PMCID: PMC7295506.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsPHPublic Health
    12. Predictors of general and health-related quality of life in Parkinson's disease and related disorders including caregiver perspectives. Parkinsonism Relat Disord. 2020 08; 77:5-10. Trang I, Katz M, Galifianakis N, Fairclough D, Sillau SH, Miyasaki J, Kluger BM. PMID: 32563809.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    13. Remote telemedicine evaluation of deep brain stimulation candidacy: Retrospective cohort analysis. Neurol Clin Pract. 2020 Jun; 10(3):199-205. Witek N, Heath SL, Ouyang B, Tanner CM, Galifianakis NB. PMID: 32642321; PMCID: PMC7292554.
      View in: PubMed   Mentions: 12  
    14. Nonsurgical Management of an Exposed Deep Brain Stimulation Lead. . 2020 Jun 1; 125-128. Brown BE, Volz VM, Heath HS, Galifianakis GN, Ostrem OJ. .
      View in: Publisher Site   Mentions:
    15. Subthalamic nucleus deep brain stimulation with a multiple independent constant current-controlled device in Parkinson's disease (INTREPID): a multicentre, double-blind, randomised, sham-controlled study. Lancet Neurol. 2020 06; 19(6):491-501. Vitek JL, Jain R, Chen L, Tröster AI, Schrock LE, House PA, Giroux ML, Hebb AO, Farris SM, Whiting DM, Leichliter TA, Ostrem JL, San Luciano M, Galifianakis N, Verhagen Metman L, Sani S, Karl JA, Siddiqui MS, Tatter SB, Ul Haq I, Machado AG, Gostkowski M, Tagliati M, Mamelak AN, Okun MS, Foote KD, Moguel-Cobos G, Ponce FA, Pahwa R, Nazzaro JM, Buetefisch CM, Gross RE, Luca CC, Jagid JR, Revuelta GJ, Takacs I, Pourfar MH, Mogilner AY, Duker AP, Mandybur GT, Rosenow JM, Cooper SE, Park MC, Khandhar SM, Sedrak M, Phibbs FT, Pilitsis JG, Uitti RJ, Starr PA. PMID: 32470421.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    16. Comparison of Integrated Outpatient Palliative Care With Standard Care in Patients With Parkinson Disease and Related Disorders: A Randomized Clinical Trial. JAMA Neurol. 2020 05 01; 77(5):551-560. Kluger BM, Miyasaki J, Katz M, Galifianakis N, Hall K, Pantilat S, Khan R, Friedman C, Cernik W, Goto Y, Long J, Fairclough D, Sillau S, Kutner JS. PMID: 32040141; PMCID: PMC7042842.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    17. Associations between spiritual well-being and quality of life in Parkinson disease. Ann Palliat Med. 2020 05; 9(3):1288-1289. Miyasaki JM, Kluger BM, Sillau S, Katz M, Galifianakis N, Prizer LP. PMID: 32312061.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    18. Correlates of spiritual wellbeing in persons living with Parkinson disease. Ann Palliat Med. 2020 Feb; 9(Suppl 1):S16-S23. Prizer LP, Kluger BM, Sillau S, Katz M, Galifianakis N, Miyasaki JM. PMID: 31735039.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    19. Education Research: An experiential outpatient teleneurology curriculum for residents. Neurology. 2019 07 23; 93(4):170-175. Afshari M, Witek NP, Galifianakis NB. PMID: 31332085.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    20. Patient Experience with Rechargeable Implantable Pulse Generator Deep Brain Stimulation for Movement Disorders. Stereotact Funct Neurosurg. 2019; 97(2):113-119. Mitchell KT, Volz M, Lee A, San Luciano M, Wang S, Starr PA, Larson P, Galifianakis NB, Ostrem JL. PMID: 31288242; PMCID: PMC6689445.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    21. Does outpatient palliative care improve patient-centered outcomes in Parkinson's disease: Rationale, design, and implementation of a pragmatic comparative effectiveness trial. Contemp Clin Trials. 2019 04; 79:28-36. Kluger BM, Katz M, Galifianakis N, Pantilat SZ, Kutner JS, Sillau S, Gritz M, Jones J, Fairclough D, Sumrall M, Hall K, Miyasaki J. PMID: 30779960.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    22. Practical Implementation Strategies for Outpatient Neurology Palliative Care. Neuropalliative Care. 2019 Jan 1; 293-301. Galifianakis GN, Katz KM, Kluger KB. .
      View in: Publisher Site   Mentions:
    23. Long-Term Outcomes of Bilateral Pallidal Deep Brain Stimulation for X-Linked Dystonia and Parkinsonism. Stereotact Funct Neurosurg. 2018; 96(5):320-326. Kilbane C, Witt J, Galifianakis NB, Glass GA, Volz M, Heath S, Starr PA, Ostrem JL. PMID: 30481788.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    24. Top Ten Tips Palliative Care Clinicians Should Know About Parkinson's Disease and Related Disorders. J Palliat Med. 2018 10; 21(10):1507-1517. Katz M, Goto Y, Kluger BM, Galifianakis NB, Miyasaki JM, Kutner JS, Jones CA, Pantilat SZ. PMID: 30204543.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    25. Neuropalliative care: Priorities to move the field forward. Neurology. 2018 07 31; 91(5):217-226. Creutzfeldt CJ, Kluger B, Kelly AG, Lemmon M, Hwang DY, Galifianakis NB, Carver A, Katz M, Curtis JR, Holloway RG. PMID: 29950434; PMCID: PMC6093769.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    26. Pallidal Deep-Brain Stimulation Disrupts Pallidal Beta Oscillations and Coherence with Primary Motor Cortex in Parkinson's Disease. J Neurosci. 2018 05 09; 38(19):4556-4568. Wang DD, de Hemptinne C, Miocinovic S, Ostrem JL, Galifianakis NB, San Luciano M, Starr PA. PMID: 29661966; PMCID: PMC5943981.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    27. Developing a First-of-its-Kind Telemedicine Rotation for Neurology Residents (P3.341). Neurology. 2018 Apr 10; 90(15_supplement). Afshari AM, Galifianakis GN. .
      View in: Publisher Site   Mentions:
    28. Telemedicine Use for Movement Disorders: A Global Survey. Telemed J E Health. 2018 12; 24(12):979-992. Hassan A, Dorsey ER, Goetz CG, Bloem BR, Guttman M, Tanner CM, Mari Z, Pantelyat A, Galifianakis NB, Bajwa JA, Gatto EM, Cubo E. PMID: 29565764.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    29. National randomized controlled trial of virtual house calls for Parkinson disease. Neurology. 2017 Sep 12; 89(11):1152-1161. Beck CA, Beran DB, Biglan KM, Boyd CM, Dorsey ER, Schmidt PN, Simone R, Willis AW, Galifianakis NB, Katz M, Tanner CM, Dodenhoff K, Aldred J, Carter J, Fraser A, Jimenez-Shahed J, Hunter C, Spindler M, Reichwein S, Mari Z, Dunlop B, Morgan JC, McLane D, Hickey P, Gauger L, Richard IH, Mejia NI, Bwala G, Nance M, Shih LC, Singer C, Vargas-Parra S, Zadikoff C, Okon N, Feigin A, Ayan J, Vaughan C, Pahwa R, Dhall R, Hassan A, DeMello S, Riggare SS, Wicks P, Achey MA, Elson MJ, Goldenthal S, Keenan HT, Korn R, Schwarz H, Sharma S, Stevenson EA, Zhu W, Connect.Parkinson Investigators. PMID: 28814455; PMCID: PMC5595275.
      View in: PubMed   Mentions: 101     Fields:    
    30. Virtual visits for Parkinson disease: A multicenter noncontrolled cohort. Neurol Clin Pract. 2017 08; 7(4):283-295. Korn RE, Wagle Shukla A, Katz M, Keenan HT, Goldenthal S, Auinger P, Zhu W, Dodge M, Rizer K, Achey MA, Byrd E, Barbano R, Richard I, Andrzejewski KL, Schwarz HB, Dorsey ER, Biglan KM, Kang G, Kanchana S, Rodriguez R, Tanner CM, Galifianakis NB. PMID: 28840919; PMCID: PMC5566796.
      View in: PubMed   Mentions: 25  
    31. Parkinson's disease patient preference and experience with various methods of DBS lead placement. Parkinsonism Relat Disord. 2017 Aug; 41:25-30. LaHue SC, Ostrem JL, Galifianakis NB, San Luciano M, Ziman N, Wang S, Racine CA, Starr PA, Larson PS, Katz M. PMID: 28615151.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    32. Chronic multisite brain recordings from a totally implantable bidirectional neural interface: experience in 5 patients with Parkinson's disease. J Neurosurg. 2018 02; 128(2):605-616. Swann NC, de Hemptinne C, Miocinovic S, Qasim S, Ostrem JL, Galifianakis NB, Luciano MS, Wang SS, Ziman N, Taylor R, Starr PA. PMID: 28409730; PMCID: PMC5641233.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    33. Palliative care and Parkinson's disease: Meeting summary and recommendations for clinical research. Parkinsonism Relat Disord. 2017 04; 37:19-26. Kluger BM, Fox S, Timmons S, Katz M, Galifianakis NB, Subramanian I, Carter JH, Johnson MJ, Richfield EW, Bekelman D, Kutner JS, Miyasaki J. PMID: 28108265.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    34. Problematic Mobile Gaming in Parkinson's Disease: An Impulse Control Disorder for the Smartphone. Mov Disord Clin Pract. 2017 Mar-Apr; 4(2):277-278. Galifianakis NB, Byrd EA, Ostrem JL, Tanner CM, Racine CA. PMID: 30838269; PMCID: PMC6353464.
      View in: PubMed   Mentions: 2     Fields:    
    35. Gamma Oscillations in the Hyperkinetic State Detected with Chronic Human Brain Recordings in Parkinson's Disease. J Neurosci. 2016 06 15; 36(24):6445-58. Swann NC, de Hemptinne C, Miocinovic S, Qasim S, Wang SS, Ziman N, Ostrem JL, San Luciano M, Galifianakis NB, Starr PA. PMID: 27307233; PMCID: PMC5015781.
      View in: PubMed   Mentions: 117     Fields:    Translation:Humans
    36. Innovative approaches in caring for people with Parkinson disease: Filling the gaps. Neurol Clin Pract. 2016 Jun; 6(3):203-205. Schneider R, Galifianakis NB. PMID: 29443141; PMCID: PMC5727715.
      View in: PubMed   Mentions:
    37. National Randomized Controlled Trial of Virtual House Calls for People with Parkinson's Disease: Interest and Barriers. Telemed J E Health. 2016 07; 22(7):590-8. Dorsey ER, Achey MA, Beck CA, Beran DB, Biglan KM, Boyd CM, Schmidt PN, Simone R, Willis AW, Galifianakis NB, Katz M, Tanner CM, Dodenhoff K, Ziman N, Aldred J, Carter J, Jimenez-Shahed J, Hunter C, Spindler M, Mari Z, Morgan JC, McLane D, Hickey P, Gauger L, Richard IH, Bull MT, Mejia NI, Bwala G, Nance M, Shih L, Anderson L, Singer C, Zadikoff C, Okon N, Feigin A, Ayan J, Vaughan C, Pahwa R, Cooper J, Webb S, Dhall R, Hassan A, Weis D, DeMello S, Riggare SS, Wicks P, Smith J, Keenan HT, Korn R, Schwarz H, Sharma S, Stevenson EA, Zhu W. PMID: 26886406; PMCID: PMC4939367.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    38. Subthalamic local field potentials in Parkinson's disease and isolated dystonia: An evaluation of potential biomarkers. Neurobiol Dis. 2016 May; 89:213-22. Wang DD, de Hemptinne C, Miocinovic S, Qasim SE, Miller AM, Ostrem JL, Galifianakis NB, San Luciano M, Starr PA. PMID: 26884091; PMCID: PMC4790450.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    39. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease. J Neurosurg. 2016 Apr; 124(4):908-16. Ostrem JL, Ziman N, Galifianakis NB, Starr PA, Luciano MS, Katz M, Racine CA, Martin AJ, Markun LC, Larson PS. PMID: 26495947.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    40. Therapeutic deep brain stimulation reduces cortical phase-amplitude coupling in Parkinson's disease. Nat Neurosci. 2015 May; 18(5):779-86. de Hemptinne C, Swann NC, Ostrem JL, Ryapolova-Webb ES, San Luciano M, Galifianakis NB, Starr PA. PMID: 25867121; PMCID: PMC4414895.
      View in: PubMed   Mentions: 248     Fields:    Translation:Humans
    41. Parkinson’s Disease (PD) Patient Experience with the ClearPoint(TM) Interventional MRI (iMRI)-Guided Method for Placement of Deep Brain Stimulation (DBS) Leads (P6.085). Neurology. 2015 Apr 6; 84(14_supplement). LaHue LS, Katz KM, Galifianakis GN, San Luciano SM, Ziman ZN, Wang WS, Racine RC, Starr SP, Larson LP, Ostrem OJ. .
      View in: Publisher Site   Mentions:
    42. Sensitive measures of executive dysfunction in non-demented Parkinson's disease. Parkinsonism Relat Disord. 2014 Dec; 20(12):1430-3. Bott NT, Johnson ET, Schuff N, Galifianakis N, Subas T, Pollock J, Pressman P, Kramer JH, Possin KL. PMID: 25454318; PMCID: PMC4314390.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    43. 203 Application Accuracy of a Second Generation Interventional MRI Stereotactic Platform. Neurosurgery. 2013 Aug 1; 60(&NA;):187. Larson LP, Starr SP, Ostrem OJ, Galifianakis GN, San Luciano Palenzuela SM, Martin MA. .
      View in: Publisher Site   Mentions:
    44. Subthalamic nucleus neurons are synchronized to primary motor cortex local field potentials in Parkinson's disease. J Neurosci. 2013 Apr 24; 33(17):7220-33. Shimamoto SA, Ryapolova-Webb ES, Ostrem JL, Galifianakis NB, Miller KJ, Starr PA. PMID: 23616531; PMCID: PMC3673303.
      View in: PubMed   Mentions: 72     Fields:    Translation:HumansCells
    45. Exaggerated phase-amplitude coupling in the primary motor cortex in Parkinson disease. Proc Natl Acad Sci U S A. 2013 Mar 19; 110(12):4780-5. de Hemptinne C, Ryapolova-Webb ES, Air EL, Garcia PA, Miller KJ, Ojemann JG, Ostrem JL, Galifianakis NB, Starr PA. PMID: 23471992; PMCID: PMC3606991.
      View in: PubMed   Mentions: 215     Fields:    Translation:HumansCTClinical Trials
    46. Globus pallidus interna deep brain stimulation for tardive dyskinesia: case report and review of the literature. Parkinsonism Relat Disord. 2013 Feb; 19(2):141-7. Spindler MA, Galifianakis NB, Wilkinson JR, Duda JE. PMID: 23099106.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    47. Clinical outcomes of PD patients having bilateral STN DBS using high-field interventional MR-imaging for lead placement. Clin Neurol Neurosurg. 2013 Jun; 115(6):708-12. Ostrem JL, Galifianakis NB, Markun LC, Grace JK, Martin AJ, Starr PA, Larson PS. PMID: 22944465; PMCID: PMC3578021.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    48. Multichannel Electromyographic Mapping to Optimize OnabotulinumtoxinA Efficacy in Cervical Dystonia. Tremor Other Hyperkinet Mov (N Y). 2012; 2. Kilbane C, Ostrem J, Galifianakis N, Grace J, Markun L, Glass GA. PMID: 23439966; PMCID: PMC3569932.
      View in: PubMed   Mentions: 3     Fields:    
    49. Multichannel Electromyographic Mapping to Optimize OnabotulinumtoxinA Efficacy in Cervical Dystonia. Tremor and Other Hyperkinetic Movements. 2012 Aug 28; 2(0):02. Kilbane KC, Ostrem OJ, Galifianakis GN, Grace GJ, Markun ML, Glass GG. .
      View in: Publisher Site   Mentions:
    50. Acute effects of thalamic deep brain stimulation and thalamotomy on sensorimotor cortex local field potentials in essential tremor. Clin Neurophysiol. 2012 Nov; 123(11):2232-8. Air EL, Ryapolova-Webb E, de Hemptinne C, Ostrem JL, Galifianakis NB, Larson PS, Chang EF, Starr PA. PMID: 22633916; PMCID: PMC3577937.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    51. Oscillations in sensorimotor cortex in movement disorders: an electrocorticography study. Brain. 2012 Feb; 135(Pt 2):615-30. Crowell AL, Ryapolova-Webb ES, Ostrem JL, Galifianakis NB, Shimamoto S, Lim DA, Starr PA. PMID: 22252995; PMCID: PMC3281473.
      View in: PubMed   Mentions: 86     Fields:    Translation:HumansCells
    52. Overview of common movement disorders. Continuum (Minneap Minn). 2010 Feb; 16(1 Movement Disorders):13-48. Ostrem JL, Galifianakis NB. PMID: 22810179.
      View in: PubMed   Mentions: 7     Fields:    
    53. Changes in regional brain perfusion during functional brain activation: comparison of [(64)Cu]-PTSM with [(14)C]-Iodoantipyrine. Brain Res. 2008 Oct 09; 1234:32-43. Holschneider DP, Yang J, Sadler TR, Galifianakis NB, Bozorgzadeh MH, Bading JR, Conti PS, Maarek JM. PMID: 18687316; PMCID: PMC2578839.
      View in: PubMed   Mentions: 2     Fields:    
    Nicholas's Networks
    Concepts (161)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (34)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-15-g9ae42700 on PROFILES-PWEB03.

    Copyright © The Regents of the University of California.